Trinity Biotech plc to Announce 2017 Third Quarter Financial Results

Date : 10/13/2017 @ 4:54AM
Source : GlobeNewswire Inc.
Stock : Trinity Biotech Plc ADS Each Representing 4 A Ordinary Shares (MM) (TRIB)
Quote : 5.49  0.0 (0.00%) @ 7:00AM

Trinity Biotech plc to Announce 2017 Third Quarter Financial Results

Trinity Biotech (NASDAQ:TRIB)
Historical Stock Chart

2 Months : From Oct 2017 to Dec 2017

Click Here for more Trinity Biotech Charts.

Trinity Biotech plc (Nasdaq:TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report 2017 third quarter financial results on Thursday, October 26, 2017. The Company has scheduled a conference call for that same day, Thursday, October 26, 2017 at 11:00am ET (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

USA:1-844-861-5499
International:1-412-317-6581
Conference ID #:10113410

A simultaneous webcast of the call can be accessed at:https://www.webcaster4.com/Webcast/Page/1135/23066

A replay of the call can be accessed until November 2, 2017 by dialing:

USA:1-877-344-7529
International:1-412-317-0088
Conference ID #:10113410

The webcast of the call will be available for 30 days at: https://www.webcaster4.com/Webcast/Page/1135/23066

Forward-looking statements in this release are made pursuant to the "safe harbor" provision of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including, but not limited to, the results of research and development efforts, the effect of regulation by the United States Food and Drug Administration and other agencies, the impact of competitive products, product development commercialisation and technological difficulties, and other risks detailed in the Company's periodic reports filed with the Securities and Exchange Commission.

Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and to quantify the level of Haemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information please see the Company's website: www.trinitybiotech.com.

ContactKevin TansleyTrinity Biotech plc(353)-1-2769800E-mail: kevin.tansley@trinitybiotech.com

Joe Diaz, Joe Dorame and Robert BlumLytham Partners, LLCInvestor Relations602-889-9700

Latest TRIB Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.